000			01999 a2200553 4500
005			20250518080201.0
264		0	_c20201211
008			202012s 0 0 eng d
022			_a1543-8392
024	7		_a10.1021/acs.molpharmaceut.9b01071 _2doi
040			_aNLM _beng _cNLM
100	1		_aKaundal, Babita
245	0	0	_aNanoformulation of EPZ011989 Attenuates EZH2-c-Myb Epigenetic Interaction by Proteasomal Degradation in Acute Myeloid Leukemia. _h[electronic resource]
260			_bMolecular pharmaceutics _c02 2020
300			_a604-621 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDrug Compounding _xmethods
650	0	4	_aDrug Delivery Systems _xmethods
650	0	4	_aEnhancer of Zeste Homolog 2 Protein _xantagonists & inhibitors
650	0	4	_aEpigenesis, Genetic _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHEK293 Cells
650	0	4	_aHL-60 Cells
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aNanoparticles _xadministration & dosage
650	0	4	_aProteasome Endopeptidase Complex _xmetabolism
650	0	4	_aProteolysis _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-myb _xgenetics
650	0	4	_aSerum Albumin, Human _xchemistry
650	0	4	_aTissue Distribution
650	0	4	_aTransfection
650	0	4	_aU937 Cells
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aSrivastava, Anup K
700	1		_aDev, Atul
700	1		_aMohanbhai, Soni Jignesh
700	1		_aKarmakar, Surajit
700	1		_aRoy Choudhury, Subhasree
773	0		_tMolecular pharmaceutics _gvol. 17 _gno. 2 _gp. 604-621
856	4	0	_uhttps://doi.org/10.1021/acs.molpharmaceut.9b01071 _zAvailable from publisher's website
999			_c30486884 _d30486884